Background Atrial fibrillation (AF) is linked to significant morbidity and mortality, with ischaemic stroke being a leading ...

Background The combination of atezolizumab and bevacizumab (ATZ/BVZ) therapy has significantly advanced therapeutic approaches for hepatocellular carcinoma (HCC). However, less than 30% of patients ...